corydine has been researched along with dicentrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, S; Chan, TM; Fischmann, T; Gullo, VP; Hegde, VR; Kirschmeier, P; Madison, V; Patel, M; Pu, H; Williams, MJ; Wu, B | 1 |
| Endo, T; Hojo, H; Imai, Y; Kondo, Y; Nozoe, S | 1 |
| Angerhofer, CK; Chai, H; Cordell, GA; Likhitwitayawuid, K; Pezzuto, JM; Ruangrungsi, N | 1 |
3 other study(ies) available for corydine and dicentrine
| Article | Year |
|---|---|
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
Topics: Aristolochic Acids; CDC2 Protein Kinase; Cell Line, Tumor; Computer Simulation; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Pyrazoles; Quinolines; Structure-Activity Relationship | 2010 |
Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine, and apomorphine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antitussive Agents; Apomorphine; Aporphines; Cell Division; Colonic Neoplasms; Evaluation Studies as Topic; Immunosuppressive Agents; Leukemia L1210; Leukemia P388; Lymphocyte Activation; Male; Melanoma, Experimental; Mice; Mitogens; Neoplasms, Experimental; Urinary Bladder Neoplasms | 1990 |
Cytotoxic and antimalarial alkaloids from the tubers of Stephania pierrei.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Aporphines; Drug Screening Assays, Antitumor; Glucosides; Isoquinolines; Magnetic Resonance Spectroscopy; Molecular Weight; Plants, Medicinal; Plasmodium falciparum; Species Specificity | 1993 |